| Literature DB >> 29349357 |
Rakesh M Patil1,2, Nanasaheb D Thorat3, Prajkta B Shete2, Poonam A Bedge4, Shambala Gavde2, Meghnad G Joshi4, Syed A M Tofail3, Raghvendra A Bohara2,4,5.
Abstract
Recently lots of efforts have been taken to develop superparamagnetic iron oxide nanoparticles (SPIONs) for biomedical applications. So it is utmost necessary to have in depth knowledge of the toxicity occurred by this material. This article is designed in such way that it covers all the associated toxicity issues of SPIONs. It mainly emphasis on toxicity occurred at different levels including cellular alterations in the form of damage to nucleic acids due to oxidative stress and altered cellular response. In addition focus is been devoted for in vitro and in vivo toxicity of SPIONs, so that a better therapeutics can be designed. At the end the time dependent nature of toxicity and its ultimate faith inside the body is being discussed.Entities:
Keywords: Biomedical applications; Cellular alteration; SPIONs; Toxicity
Year: 2018 PMID: 29349357 PMCID: PMC5766481 DOI: 10.1016/j.bbrep.2017.12.002
Source DB: PubMed Journal: Biochem Biophys Rep ISSN: 2405-5808
Fig. 1Schematic representation of possible mechanism of SPIONs interaction and SPIONs-induced toxicity at cellular level.
A brief account of in vitro toxicity of SPIONs (bare as well as coated) on different cell types using different cytotoxic assays Adapted from Ref. [58].
| CNS | astrocytes (human Nerve cells) | – | MTS and LDH | 10 μg/mL | 6 | significantly (p < 0.01) increased MTS production revealed alteration in mitochondrial function | |
| Schwann cell | Dextran | dyes (PI) | up to 4 mg/mL | 48 | No change in cell viability | ||
| Glioma | tetramethyla mmonium11-aminoundecanoate | 0.1–100 μg/mL | 24 | concentration dependent toxicity | |||
| GL261 (mouse brain) | Dextran | MTT | 1–200 μg/mL | 24 | Higher toxicity was exhibited as compared to bare one | ||
| Liver | BRL 3A (rat) | MTT | 0–250 μg/mL | 24 h | concentration dependent and 50% decrease in viability at 250 μg/mL | ||
| BRL 3A (rat) | LDH | 0–250 μg/mL | 24 | toxic effect at 250 μg/mL was reported | |||
| HepG2 (human) | Baavi-b USPIO | MTT | no indication of cytotoxicity | ||||
| HepG2 (human) | amino-surface | MTT | 0.03 μg/mL to 3 mg/mL | 5 days | LD50 of Gal-ASPIO-278 = 1500 μg/mL | ||
| HepG2 (human) | amine-surface | Cytochrome C | 0.03–3000 μg/mL | 4 h to 5 days | The toxicity is associated with the zeta potential of NPs | ||
| SMMC-7721 (human hepatocellular) | Chitosan | MTT | 0–123.52 μg/mL | Bare MNPs showed decreased cell viability as compared to coated one | |||
| Pancreas | human islet | Dextran | dyes (PI) | 280 μg/mL | viability of labelled islets were similar to the control islets | ||
| Kidney | Cos-7 (monkey) | MTT | 0.2–23.05 Mm | no toxicity detected | |||
| Skin | dermal fibroblasts (human) | PEG, insulin | MTT | 0–1 mg/mL | 24 h | 25–50% decrease in viability for bare particles (250 μg/mL); | |
| 99% viability for PEG-coated (1 mg/mL) | |||||||
| HEK | Dextran | MTT, alamar blue | 0–26 μg/cm2 | 24 h | Size depended toxicity has been seen. 20 nm particles had shown a decrease in cell viability, while the 15 and 50 nm particles were not cytotoxic. | ||
| Murine epidermal cells (JB6 P+) | Dextran | MTT, alamar blue | 0–26 μg/cm2 | 24 h | activation of AP-1, 5% reduction in cell viability at the highest dose evaluated (26 μg/cm2) | ||
| dermal fibroblasts (human) | sodium oleate | MTT | 0–1000 μg/mL | 24 h | bare SPIONs shown disrupted cytoskeleton | ||
| Lactoferrin or ceruloplasmin coated SPIONs attached to the cell membrane | |||||||
| hTERT-BJ1 (human) | dextran and albumin- derivatized | dyes (BrdU) | 0.05 mg/mL | 24–72 h | Albumin-coated particles shown more cell viability as compared to bare and dextran coated | ||
| L929 (mouse) | PVA | dyes (crystal violet) | 800 mM | 72 h | confirmed the presence of gas vesicles inside Cells | ||
| L929 (mouse) | PVA | MTT | 0.2 mM | 24 h | morphology and size dependent toxicity | ||
| L929 (mouse) | PEGF and PVA | MTT | 0.4–1.6 M | 24–72 h | morphology and size dependent toxicity | ||
| L929 (mouse) | PEGF | dyes (NR) | 800 mM | 24–72 h | concentration@800 mM did not change the cell shapes notably and cells appeared not to be damaged | ||
| L929 (mouse) | PAA | MTT | 48 h | No observable toxicity was found | |||
| L929 (mouse) | Chitosan | MTT | 48 h | No observable toxicity was found | |||
| L929 (mouse) | Chitosan/Glutar-aldehyde | MTT | 24 h | No observable toxicity was found | |||
| L929 (mouse) | Oleic acid/betain HCl | MTT | 24 h | No observable toxicity was found | |||
| 3T3 (mouse) | MTT | 0–30 ppm | 72 h | no significant difference in the toxicity | |||
| HS68 (human foreskin) | ethylene glycol | MTT | 1 mg/mL | 24 h | no significant difference in the viability of Cells | ||
| Melanoma (human) | PVA and vinyl alcohol/vinyl amine copolymer | MTT | 12, 61, and 123 μg/mL | 2 and 24 h | polymer alone (was more toxic than polymer-coated SPIONs; | ||
| SK-MEL-37 (human melanoma) | DMSA, citric acid or lauric acid | MTT | up to 840 μg/mL | cell viability decreased in a dose-dependent manner | |||
| HaCaT | MTT | 0.01–100 mg/mL | 24 h | cell viability decreased in a dose-dependent manner | |||
| Blood | J774 (murine) | Tween 80 | MTT | 25–500 μg/mL | 1–6 h | Enhanced ROS generation, leading to cell injury and death; concentration- and time- dependent damage | |
| macrophages(human) | dextran | MTS and dyes (BrdU) | 100 μg/mL | 7 days | 20% of macrophages were viable after 7 days | ||
| Mouse | WST-1 | higher degree of necrosis due to rod shaped | |||||
| macrophage cells (RAW264.7) | LDH | Fe2O3was in correlation with both the higher degree of membrane damage and ROS Production | |||||
| human monocyte macrophage | dextran | MTT and NBT | 1 and 10 mg/mL | up to 14 days | only mildly toxic at the highest applied dosage (i.e., particle concentration of 10 mg/mL) | ||
| K562 (human leukemia) | Tetraheptyl- ammonium | MTT | 2.5 μg/mL | 72 h | inhibition rate = 46% for the cell system incubated with Fe3O4-PLA | ||
| K562 and K562/A02 (human leukemia) | ADM conjugated | MTT | 20 μg/mL to 5 mg/mL | 48 h | cell proliferation significantly (P < 0.001) | ||
| T lymphocyte cell line (rat) | scAbCD3 | Tetrazolium | 0.15 μg | 48 h | no detectable toxicity | ||
| Muscles | A10 (rat) | polylactide | Redox | 10–50 μg/mL | 72 h | no detectable toxicity | |
| Lung | A549 (human) | dyes (TB) and ROS | up to 80 μg/mL | 18 h | no or low toxicity | ||
| A549 (human) | Comet | up to 80 μg/mL | 4 h | oxidative DNA lesions in cultured A549 cells after exposure to 40 μg/mL and 80 μg/mL SPIONs | |||
| A549 (human) | silica | MTT | 4 mg/mL | IC50 = 4 mg/mL | |||
| H441 (human) | PEI | MTT | 90 μg/mL | 24–48 h | Toxicity of tested complexes was acceptable (cell viability > 80%) | ||
| LLC (mouse) | poly(TMSM A- | MTT | 1–100 μg/105 cells | 12 h | no indication of toxicity | ||
| Mesenchyma | MSC (human) | PLL | MTT | 1–43 days | long-term viability, and apoptotic indices were unaffected | ||
| MSC (human) | comet | 50–250 μg/mL | 24–72 H | Did not affect the apoptosis | |||
| rMSC (rat) and MSC (human) | PDMA | Tetrazolium | 15 μg γ-Fe2O3/mL | 24 h | The viability with coating was more as compare to bare | ||
| rMSC (rat) | HEDP | MTS | 25, 50, and 100 μg iron/mL | 48 h | Concentration dependent toxicity | ||
| Heart | BAECs | redox | 90 μg/mL | 24 h | cell viability was not adversely affected by internalized SPIONs; | ||
| Breast | B16/DNS and B16/phOx (mouse breast) | DNS hapten covalently attached to CLIO | ATP | 100 mM | 48 h | DNS-CLIO was nontoxic to B16/DNS (DNS receptor positive) and B16/phOx (control receptor positive) cells | |
| MCF-7 (human breast) | dextrane and phosphatidyl choline/cholesterol | MTT | 100 μg/mL | 1–3 days | presence of SPIONs in culture medium led to | ||
| alterations in mitochondria ultrastructural | |||||||
| organization and decrease of oxygen uptake by | |||||||
| mitochondria in sensitive and anticancer drugs resistant cells | |||||||
| H184B5F5/M10, SKBR3 (normal breast), | MTS | 0.1, 1, 10, and 100 μM | 72 h | no observable change in cell viability | |||
| B16F10 (mouse breast) | CMC | XTT | 1–5 mM | 24 h | after 48 h, cell viability was reduced (81%) at concentrations > 1 mM | ||
| Prostate glands | PC3 (human prostate) | TCL-SPIONs | MTT | 0.1 mg/mL | 48 h | cytotoxicity was comparable to free Dox | |
| Cervix | HeLa (human cervical) | PLL | MTT | 1–43 days | long-term viability, growth rate, and apoptotic | ||
| indices of the labelled cells were unaffected by | |||||||
| the endosomal incorporation of SPIONs | |||||||
| HeLa (human cervical) | dextran, amino-dextran, heparin, and dimer-captosuccinic acid | MTT | 0.05–0.5 mg/mL | 24 h | viability of cell culture was not significantly Affected | ||
| KB (human carcinoma) | PAMAM and G3 | XTT | 0–80 mg/mL | 4 days | dendrimer-stabilized SPIONs did not display cytotoxicity to KB cells in the predetermined concentration range | ||
| Cancer | MSTO-211H (human) | MTT | 0–30 ppm | 72 h | Concentration depended toxicity | ||
| HMMs (human) | dextran | MTT | 0–10 mg/mL | 24, 48, 72 h | not toxic at particle concentration of 1 mg/mL and mildly toxic at particle concentration of 10 mg/mL after 72 h |
Abbreviations of cell types: hTERT-BJ1, Infinity Telomerase Immortalized primary human fibroblasts; L929, mouse fibroblast cell; rodent 3T3, Swiss mouse fibroblast cells; HS68, human foreskin fibroblast cells; HEK, normal human epidermal keratinocytes; A549, human lung adenocarcinoma epithelial cells; H441, human lung adenocarcinoma epithelial cells; BRL 3A, rat liver cells; HepG2, human liver hepatocellular cells; MSCs, mesenchymal stem cells; rMSCs: rat mesenchymal stem cells; Cos-7, obtained by immortalizing a CV-1 cell line derived from kidney cells of the African green monkey; OCTY, mouse kidney cells; J774, murine macrophage cells; Schwann, principal glia of the peripheral nervous system; BAECs, bovine aortic endothelial cells; HeLa, cervical cancer cells; LLC, mouse Lewis lung carcinoma; GL261, mouse brain tumor cells; K562, human immortalized myelogenousleukemia cells; k562/A02, human leukemiacells; B16, mouse melanoma cells; B16/DNS, mouse melanoma cells with DNS receptor positive; B16/phOx, mouse melanoma cells with control receptor positive; SMMC-7721, human hepatocellular carcinoma cells; PC3, human prostate cancer cells; A2780, human ovarian cancer cells; MCF-7, human breast cancer cells; SK-MEL-37, human melanoma cells; KB, human epithelial carcinoma cells; H184B5F5/M10, normal breast epithelial cells; B16F10, SKBR3, MB157, and T47D, three types of breast cancer cells; MSTO-211H, human lung mesothelioma cells; HMMs, human malignant mesothelioma cells; HaCaT, human keratinocyte cells; A10, rat aortic smooth muscle cells.
Abbreviation of coatings: Baavi-bUSPIO, (Avidin-coated baculoviral vectors-biotinylated ultra-small superparamagnetic iron oxide nanoparticles); PEG, poly(ethylene glycol); PEGF, poly(ethylene glycol-co-fumarate); PLL, poly(l-lysine); PVA, poly(vinyl alcohol); PEI, polyethyleneimine; ADM, adriamycin; TCL-SPIONs, thermally cross-linked SPIONs; DMSA, meso-2,3-dimercaptosuccinic acid; HEDP, 1-hydroxyethylidene-1.1-bisphosphonic acid; PAA, poly(acrylic acid); MPEG, methoxypoly(ethylene glycol)-oligo(aspartic acid)); WSC, water-soluble chitosan; LA, linoleic acid; PAMAM, dendrimer-stabilized (carboxyl-functionalized poly(amidoamine); G3, dendrimers of generation 3; CMC, carboxymethylCurdlan; CLIO, cross-linked iron oxide; PDMA, poly(N,Ndimethylacrylamide); scAbCD3, nonviral gene delivery agent bearing CD3 single chain antibody. c Abbreviation of toxicity methods: MTT, (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide); MTS, (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium); XTT, (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide); BrdU, bromodeoxyuridine; LDH, lactate dehydrogenase; ATP, adenosine triphosphate; NBT, Nitrobluetetrazolium; WST, water-soluble tetrazolium; PI, propidium iodide.